Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up-Reference-Cited by-同舟云学术

Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Published:2009-05 Issue: Volume:20 Page:iv41-iv45
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Jelic S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/suppl_4/iv41/345006/mdp124.pdf

Reference21 articles.

1. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients;Tanaka;Int J Cancer,2000

2. Randomised trial of effects of interferonalpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis;Nishiguchi;Lancet,1995

3. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

4. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy;Llovet;Hepatology,2000

5. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma;Leung;Clin Cancer Res,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ultrasound-guided radiofrequency ablation combined with transhepatic artery embolization chemotherapy for hepatocellular carcinoma: A meta-analysis;PLOS ONE;2024-09-06

2. A comprehensive analysis of GAS2 family members identifies that GAS2L1 is a novel biomarker and promotes the proliferation of hepatocellular carcinoma;Discover Oncology;2024-06-10

3. Mendelian randomization analysis identified serum palmitoylcarnitine as a biomarker for hepatocellular carcinoma;2024-01-03

4. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma;Journal of Cancer Research and Therapeutics;2018

5. Correction: Radioembolization with yttrium-90 microspheres;ONKOLOGE;2017